AC Immune ACIU Cash Flow Statement (2014-2026)

NASDAQ ACIU
$2.47 -0.02 (-0.60%)
As of: Oct 21, 2026 · 3:41 PM EDT
Reported Financials

AC Immune Quarterly Cash Flow Statement

Periods 45 quarters
Latest Jun 2026

AC Immune cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 45 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2014 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-17.34M-23.07M-20.41M-20.40M-14.00M-19.46M-18.93M-18.72M-17.14M-5.35M-20.46M-25.17M6.35M-18.03M-21.17M-25.59M-19.82M-17.98M-18.90M2.37M
Depreciation and DepletionDep. & Depletion
0.54M0.53M0.50M0.45M0.45M0.48M0.47M0.45M0.47M0.47M0.45M0.42M0.41M0.41M0.40M0.44M0.43M0.41M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.54M0.53M0.50M0.45M0.45M0.48M0.47M0.45M0.47M0.47M0.45M0.42M0.41M0.41M0.40M0.44M0.43M0.41M
Share-based CompensationStock Comp.
1.51M1.13M1.07M0.93M0.57M0.92M1.59M1.37M0.98M0.90M2.16M1.54M1.42M1.10M1.73M1.35M1.02M1.13M
Cash from Discontinued OperationsCash from Discont. Ops
-15.79M-25.06M-20.23M-14.02M-18.16M1.17M120.18M-22.07M-140.84M
Gains from Sales and DivestituresGains Divest
-0.04M0.04M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
-4.80M-1.63M0.15M-0.19M0.07M0.35M0.14M0.14M0.16M1.39M0.19M0.38M-0.01M0.41M0.28M1.93M-1.34M1.56M
Change in Working Capital
Change in ReceivablesChange Receivables
16.96M-32.73M5.77M-5.71M
Change in Account PayablesChange Payables
-0.08M1.97M-1.62M-0.09M1.25M-0.73M0.22M0.25M0.15M0.23M1.32M-1.55M-0.02M1.42M-0.42M0.75M-1.46M0.41M
Change in Accured ExpensesChange Accured Exp.
-1.58M-3.35M-5.55M10.50M-0.56M1.74M-0.81M1.54M-0.83M-1.17M-0.03M-1.44M4.23M-4.23M-1.06M1.90M-0.91M4.96M
Change in Other Operating AssetsOther Assets Change
-4.87M2.22M0.20M-0.24M3.18M-1.98M-0.80M1.54M-1.69M3.00M2.89M-4.90M5.66M-4.43M0.77M-3.13M3.63M-2.82M
Change in Other Operating LiabilitiesOther Liabilities Change
0.02M0.75M0.20M-0.21M0.29M0.16M0.14M0.30M0.18M-0.14M0.06M101.28M-105.61M101.96M0.11M-2.66M0.71M-4.49M
Other Working Capital ChangesOther WC Changes
4.88M-1.47M0.00M0.02M-2.89M2.15M0.94M-1.24M1.87M-3.14M-2.83M106.18M-111.26M106.39M-0.67M0.48M-2.92M-1.67M
Other Operating ActivitiesOther Ops.
0.06M0.07M0.14M0.22M0.23M0.41M0.43M0.42M0.52M0.66M0.80M0.48M0.33M
Cash from OperationsCash from Ops.
-15.79M-19.33M-25.06M-20.23M-14.02M-18.07M-18.16M-15.70M-15.33M-17.98M1.17M80.75M-16.32M6.77M-21.53M-18.19M-24.78M-18.80M
Investing Activities
Capital ExpendituresCapex
3.63M0.78M-0.58M1.68M0.13M0.04M-0.22M0.62M-1.12M1.62M-0.29M0.63M-0.93M1.21M-0.40M1.33M-1.91M2.12M
Change in Property, Plant and EquipmentChange in PP&E
-3.63M-0.78M0.58M-1.68M-0.13M-0.04M0.22M-0.62M1.12M-1.62M0.29M-0.63M0.93M-1.21M0.40M-1.33M1.91M-2.12M
Purchase of InvestmentsInvestments Purchased
-22.77M-5.18M5.19M46.49M-5.56M5.66M26.43M-26.65M-83.76M-2.21M-4.26M
Other Investing ActivitiesOther investing
-26.86M-0.58M58.05M-37.86M46.27M-26.99M-166.01M29.57M186.27M
Cash from Investing ActivitiesCash from Investing
-0.54M-23.56M-0.58M25.40M-5.30M5.15M46.27M-5.73M5.34M26.24M-26.99M-83.84M-2.41M-4.37M3.37M28.85M25.79M20.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Non-Current Debt
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
13.41M-12.25M0.00M0.01M0.00M-0.01M-0.01M0.08M0.01M0.00M0.00M0.00M-0.01M0.01M0.01M0.00M
Net Shares Issued and RepurchasedNet Shares Issued
13.41M-12.25M0.00M0.01M0.00M-0.01M-0.01M0.08M0.01M0.00M0.00M0.00M-0.01M0.01M0.01M0.00M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
13.41M-12.25M0.00M0.01M0.00M-0.01M-0.01M0.08M0.01M0.00M0.00M0.00M-0.01M0.01M0.01M0.00M
Other financing activitiesOther financing
-0.16M-0.16M-0.84M0.51M-0.95M0.66M-0.15M-0.15M-0.16M-0.16M-0.19M-0.19M-0.20M-0.20M-0.28M-0.31M-0.32M-0.33M
Cash from Financing ActivitiesCash from Financing
4.71M31.16M-0.99M-0.14M-0.15M-0.16M-0.15M2.13M0.51M46.25M-0.79M-0.07M-3.63M-0.22M-0.29M-0.30M0.21M-0.33M
Additional items
Exchange Rate EffectFX Effect
0.13M-0.60M0.24M0.48M0.16M-0.33M-0.01M-0.08M0.06M-1.75M1.99M-2.87M-3.17M2.22M-0.30M-2.75M-0.02M-0.23M
Change in Cash
-11.62M-11.73M-26.64M5.03M-19.47M-13.08M27.96M-19.30M-9.21M54.24M-26.61M-3.15M-49.46M2.18M-17.85M9.71M45.64M-0.96M
Ending Cash Balance
100.17M176.09M62.66M86.16M45.65M89.09M62.88M35.13M34.90M93.07M63.27M87.36M38.57M40.16M22.66M32.22M34.80M33.84M34.37M
Free Cash FlowFCF
-19.42M-20.12M-24.47M-21.91M-14.14M-18.11M-17.95M-16.32M-14.21M-19.60M1.46M80.13M-15.40M5.56M-21.13M-19.51M-22.87M-20.91M
Net Cash FlowNCF
-11.62M-11.73M-26.64M5.03M-19.47M-13.08M27.96M-19.30M-9.48M54.52M-26.61M-3.15M-22.36M2.18M-18.45M10.36M1.21M0.90M
Interest Paid
0.37M0.14M-0.14M0.47M0.06M0.10M-0.10M0.24M-0.30M0.34M-0.04M0.10M-0.17M0.23M-0.05M0.17M-0.29M0.39M

AC Immune Cash Flow Statement API

Pull AC Immune's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACIU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY